Demonstration of the yeasticidal efficacy of povidone-iodine–based commercial antiseptic solutions against Candida auris - 02/12/21
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 3 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Candida auris is an emerging yeast pathogen with worldwide distribution and a great propensity for nosocomial spread. Recent reports have warned of the significant emergence of C. auris in several healthcare facilities. In order to stop its nosocomial transmission, use of antiseptics constitutes the first-line lever of action in the fighting against C. auris skin colonization. However, little is known about the efficacy of these products, and moreover no antiseptics are currently registered for use against C. auris. This study investigated the in vitro yeasticidal activity of povidone-iodine against C. auris, and compared the findings to C. albicans and C. glabrata, according to the EN standard 1275:2005. Results support the use of such commercial antiseptics in the context of colonization with this yeast.
Le texte complet de cet article est disponible en PDF.Keywords : Candida auris, Povidone-iodine, EN 1275
Plan
| Author contribution: AC was involved in the writing of the text; EB was involved in the concept of the study and in the reviewing of the text; GD was involved in the concept of the study, in the research of sponsors, and in the reviewing of the text. |
Vol 31 - N° 4
Article 101173- décembre 2021 Retour au numéro
Article précédent
- Apophysomyces variabilis, an emerging and worrisome cause of primary cutaneous necrotizing infections in India
- Jagdish Chander, Nidhi Singla, Mandeep Kaur, R.P.S. Punia, Ashok K. Attri, Ana Alastruey-Izquierdo, Alberto Stchigel, Jose F. Cano-Lira, Josep Guarro
- Corrigendum to ’Outbreak of Trichophyton soudanense causing tinea capitis in an orphanage in Myanmar’ [J Mycol Med 30 (2020) 101013]
- S. Norrenberg, M. Monod, S. Christen-Zaech
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?